Gastrin Plays Significant Role In Helicobacter-Induced Stomach Cancer

Main Category: Cancer / Oncology
Also Included In: GastroIntestinal / Gastroenterology;  Infectious Diseases / Bacteria / Viruses;  Clinical Trials / Drug Trials
Article Date: 25 Jun 2009 - 3:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

A group led by Columbia University Medical Center's Timothy Wang, M.D., has studied the role of Helicobacter infection in the development of stomach cancer and found that the hormone gastrin, which stimulates secretion of gastric acid, plays a key role in the development of Helicobacter-induced stomach cancer, and may have distinct effects on carcinogenesis in different parts of the stomach.

More than 50 percent of the world's population is infected with Helicobacter, which causes chronic inflammation of the stomach lining and is strongly linked to the development of gastric ulcers and stomach cancer. Stomach cancer is the second leading cause of cancer-related deaths worldwide.

Helicobacter infection results in increased expression of gastrin, although its role in cancer development has been unclear. High levels of gastrin lead to the development of stomach cancer, but absence of gastrin has been shown to increase the numbers of tumors in the gastric antrum, the lower section of the stomach that empties into the small intestine.

To reconcile this apparent discrepancy, a group led by Dr. Wang studied Helicobacter infection and stomach cancer in animal models with either high expression of gastrin or no gastrin at all. They found that Helicobacter infection in mice with high levels of gastrin resulted in cancer of the gastric corpus (main body of the stomach), whereas infection in gastrin-deficient mice developed cancer in the gastric antrum.

The latest research by Dr. Wang and his colleagues appears in the July 2009 issue of The American Journal of Pathology.

Dr. Wang, with CUMC's Dr. Shigeo Takaishi, and their colleagues, argue that gastrin may serve as a "rheostat" for the stomach. Gastrin likely plays a central role in the safety network for the protection from mucosal damage caused by gastric acid secretion induced by gastrin itself, and thus either too much or too little gastrin could predispose a person to stomach cancer. Therefore, clinicians in the future may need to be more careful about prescribing acid-suppressive drugs for long-term use in patients infected with Helicobacter, Dr. Wang says.

In future studies, Dr. Wang and colleagues plan to study "host factors other than gastrin that are also important for Helicobacter-associated gastric carcinogenesis." These include specific cytokines and chemokines induced by Helicobacter infection and modulated by gastrin, that link inflammation and cancer. In addition, they plan to study the role of other non-Helicobacter bacteria that colonize the stomach when acid secretion is suppressed, since bacterial overgrowth likely contributes to gastric carcinogenesis.

The work was supported by grants from the National Institutes of Health, the Medical Research Council, the Welcome Trust and the Wolfson Foundation.

Columbia University Medical Center provides international leadership in basic, pre-clinical and clinical research, in medical and health sciences education, and in patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians & Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Established in 1767, Columbia's College of Physicians & Surgeons was the first institution in the country to grant the M.D. degree. Among the most selective medical schools in the country, the school is home to the largest medical research enterprise in New York State and one of the largest in the country.

The American Journal of Pathology is the official journal of the American Society for Investigative Pathology. It seeks to publish high-quality, original papers on the cellular and molecular biology of disease. The editors accept manuscripts that advance basic and translational knowledge of the pathogenesis, classification, diagnosis, and mechanisms of disease, without preference for a specific analytic method. High priority is given to studies on human disease and relevant experimental models using cellular, molecular, animal, biological, chemical, and immunological approaches in conjunction with morphology.

Source: Columbia University Medical Center